Please wait while the formulary information is being retrieved.
HISTATROL PERCUTANEOUS (histamine phosphate)
- Desensitization to allergen
Histatrol 1 mg/mL (2.75 mg/mL) percutaneous solution
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Abnormal vasomotor function
- Acute asthma attack
- Acute respiratory insufficiency
- Hypotension
- Severe cardiac disease
- Severe renal impairment
- Severe uncontrolled hypertension
Contraindicated
- Asthma
Severe
Moderate
- None
HISTATROL PERCUTANEOUS (histamine phosphate)
- Desensitization to allergen
- Hypertension
- Hypotension
- Nervousness
- Severe headache disorder
- Tachycardia
- Abdominal pain with cramps
- Diarrhea
- Dysgeusia
- Injection site sequelae
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Blurred vision
- Chest pain
- Dyschromia
- Dyspnea
- Flushing
- Seizure disorder
- Severe diarrhea
- Severe vomiting
Less Severe
- Nausea
- Severe nausea
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Histamine
Lower skin reactivity age < 6 years.
- 1 Day – 6 Years
- Lower skin reactivity age < 6 years.
Histamine Phosphate
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Histamine
No data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | No data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Desensitization to allergen | |
| Z51.6 | Encounter for desensitization to allergens |
| 0-9 | A-Z |
|---|---|
| Z51.6 | Encounter for desensitization to allergens |
Formulary Reference Tool